Differential expression of peroxiredoxins in prostate cancer: Consistent upregulation of PRDX3 and PRDX4

Abstract

PRDXs exhibit differential expression in prostate tumors, with PRDX3 and 4 consistently upregulated. Their role in PCa development, and their potential as biological determinants of PCa health disparities and novel therapeutic targets, deserve further investigation.